6 TECH OUTLOOKNovember - 2019EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comCompliance in the pharmaceutical domain is extremely dynamic and volatile. Regulations by leading bodies like food and drug administration (FDA) are always on a turn to shape the regulatory scenario of the pharma tech market. Moreover, with rising data theft and cybersecurity issues, and medical fraud, FDA has laid profound attention on regulatory policies for drug manufacturers.Last year, we saw multiplying compliance standards such as PCI, HIPAA, and more. However, 2019 is bringing a more wholesome view to the compliance industry where pharmaceutical companies increasingly understand the critical value of regulatory operations in the drug monitoring and clinical trials. There is a heavy flow of investment being directed toward building an international regulatory team to ensure local expertise throughout the country. These compliance teams will ensure smooth and timely regulatory approval by undertaking various technological tools like artificial intelligence (AI), data analytics, et al.Having said that, considering the changing realm of the pharmaceutical industries, it is imperative to develop further the tools at hand as well as reiterate old approaches while we come up with the new ones, technological applications, and innovative compliance systems to optimize medical and pharma tech services and platforms. Greater integration with policymakers as well will go far to help migrate the value of such technologies. Indeed, many of those currently available help to increase access and immediacy of drug trials. A heavy downpour of innovation and integrative advocacy is just what the ecosystem needs right now.In the wake of such trends shaping the compliance in the pharma tech domain, putting together this edition has been an exciting journey for us. This edition also blends thought leadership articles, from subject-matter experts with real-life stories, on what selected vendors are doing for their clients, including exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best-in-class compliance management vendors for your requirements.Let us know your thoughts!A Big Leap to Transforming Compliance in PharmaCopyright © 2019 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.NOVEMBER - 01 - 2019, Vol 05 - Issue 16 (ISSN 2644-2787) Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405Scott JuasyTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >